Roche Resources is intended for UK Healthcare Professionals only. By entering this site you are confirming that you are a UK Healthcare professional.

Skip to main content
Connect with our team

Click on the relevant region below to contact your local Roche representative; disease level partner (DLP) or clinical educator (CE)

Disease Level Partner
Eva McCleery

eva.mccleery@roche.com

Contact Eva
Disease Level Partner 
Andy Currie

andy.currie@roche.com

Contact Andy
Clinical Educator
Kirsty Ioannou

kirsty.ioannou@roche.com

Contact Kirsty
Disease Level Partner
Junaid Hussain

junaid.hussain@roche.com

Contact Junaid
Clinical Educator
Rachael Thirlwall

rachael.thirlwall@roche.com

Contact Rachael
Disease Level Partner
Emma Reynolds

emma.reynolds@roche.com

Contact Emma
Clinical Educator
Rachael Thirlwall

rachael.thirlwall@roche.com

Contact Rachael
Disease Level Partner
Suki Athwal

suki.athwal@roche.com

Contact Suki
Clinical Educator
Patricia Wallace

patricia.wallace@roche.com

Contact Patricia
Disease Level Partner
Kate Bass

kate.bass@roche.com

Contact Kate
Clinical Educator
Eniola Kuti

eniola.kuti@roche.com

Contact Eniola
Disease Level Partner
Nandika Mitchell

nandika.mitchell@roche.com

Contact Nandika
Clinical Educator
Patricia Wallace

patricia.wallace@roche.com

Contact Patricia
Disease Level Partner
Shelley Shanker

shelley.shanker@roche.com

Contact Shelley
Clinical Educator
Jane Ware

jane.ware@roche.com

Contact Jane
Disease Level Partner
Kelsey Simmonds

kelsey.simmonds.ks1@roche.com

Contact Kelsey
Clinical Educator
Eniola Kuti

eniola.kuti@roche.com

Contact Eniola
Disease Level Partner
Scott Forde

scott.forde@roche.com

Contact Scott
Clinical Educator
Jane Ware

jane.ware@roche.com

Contact Jane

References:

  1. OCREVUS SC Summary of Product Characteristics
  2. OCREVUS IV Summary of Product Characteristics
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. You can also report via the free Yellow Card app available from the Apple App Store or Google Play Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 367554.

Adverse reactions should be reported by brand name and batch number.
You are about to leave the rocheresources.co.uk environment and will be redirected to another site or resource which may contain information not intended for a UK audience. Roche Products Limited does not endorse or accept liability for sites or resources controlled by third parties.